TrialJournal of pharmacokinetics and pharmacodynamics2016

Study design and population pharmacokinetic analysis of a phase II dose-ranging study of interleukin-1 receptor antagonist.

Kayode Ogungbenro et al.PubMed ↗Publisher ↗

No numbers read from the abstract.